Owner Targanta Therapeutics Inc.

Inventors Lafontaine, Yanick; Houghton, Tom; Tanaka, Kelly; Rafi Far, Adel; Dietrich, Evelyne; Delorme, Daniel; Kang, Ting

Agent Shelston IP

Pub. Number AU-A-2006277682

PCT Pub. Number WO2007/017762

Priority 60/673,336 21.04.05 US

Filing date 21 April 2006

Wipo publication date 15 February 2007

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/65 (2006.01) - Tetracyclines

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups